Cargando…

Long-term anifrolumab safe in SLE

Detalles Bibliográficos
Autor principal: McHugh, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809509/
https://www.ncbi.nlm.nih.gov/pubmed/36596927
http://dx.doi.org/10.1038/s41584-022-00902-4
_version_ 1784863141630312448
author McHugh, Jessica
author_facet McHugh, Jessica
author_sort McHugh, Jessica
collection PubMed
description
format Online
Article
Text
id pubmed-9809509
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98095092023-01-04 Long-term anifrolumab safe in SLE McHugh, Jessica Nat Rev Rheumatol In Brief Nature Publishing Group UK 2023-01-03 2023 /pmc/articles/PMC9809509/ /pubmed/36596927 http://dx.doi.org/10.1038/s41584-022-00902-4 Text en © Springer Nature Limited 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle In Brief
McHugh, Jessica
Long-term anifrolumab safe in SLE
title Long-term anifrolumab safe in SLE
title_full Long-term anifrolumab safe in SLE
title_fullStr Long-term anifrolumab safe in SLE
title_full_unstemmed Long-term anifrolumab safe in SLE
title_short Long-term anifrolumab safe in SLE
title_sort long-term anifrolumab safe in sle
topic In Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809509/
https://www.ncbi.nlm.nih.gov/pubmed/36596927
http://dx.doi.org/10.1038/s41584-022-00902-4
work_keys_str_mv AT mchughjessica longtermanifrolumabsafeinsle